APP.com -- Johnson & Johnson may consider acquisitions worth more than $10 billion in order to bolster growth as the company’s cash balance rises to record highs, said David Lewis, an analyst with Morgan Stanley in San Francisco.
J&J, the world’s second biggest seller of health-care products, may be looking for consumer goods outside the U.S., as well as acquisitions in medical devices and diagnostics, Lewis said in a note to clients today. He said he has no knowledge of any potential deals being sought by the New Brunswick, New Jersey-based company.
